WOW Brooke Chapman did it! An RCT of tube feeds in people waiting for liver transplant 1️⃣everyone missing nutritional goals at baseline 2️⃣massive ⬆️in calories and protein 3️⃣⬆️strength and immune function pubmed.ncbi.nlm.nih.gov/38456800/ Not powered for clinical outcomes #livertwitter

Another wow for this group: it’s the macronutrient targets that matter in #cirrhosis BCAA supplements without improvement in muscle or quality of life. Non-significant improvement in strength. Cannot emphasize how impressive this group has been. On absolute fire. Thank you

Long-term continuous terlipressin infusion improves cardiac reserve in patients with decompensated cirrhosis - Clinical Gastroenterology and Hepatology cghjournal.org/article/S1542-…

Bookings now open for the Austin Health ACTER Advanced Liver Disease Symposium 2025, featuring guest speaker Elliot Tapper. Maximising quality of life and survival in cirrhosis. trybooking.com/events/landing…

❗️Progressive systemic inflammation precedes decompensation in compensated cirrhosis 🔓#OpenAccess at👉jhep-reports.eu/article/S2589-… #LiverTwitter #cirrhosis 🙏Agustín Albillos et al.

I went to Australia and got to meet the worlds foremost liver dietician

Link: cghjournal.org/article/S1542-…

Original Article Comparison of pharmacological therapies in metabolic dysfunction–associated steatohepatitis for fibrosis regression and MASH resolution: Systematic review and network meta-analysis Souza et al. Rohit Loomba #LiverX

Everything you need to know about terlipressin journals.lww.com/hepcomm/fullte… Hepatology Communications Adam Testro Marie Sinclair

Original Article Determining safe washout period for immune checkpoint inhibitors prior to liver transplantation: An international retrospective cohort study Moeckli et al. #LiverX tinyurl.com/yrt77t4k

#Hep_Highlights: From Frail to Free: How Liver Transplantation Defies Frailty's Limits Frailty isn’t futile: Liver transplantation offers survival benefits at all levels of frailty. No threshold justifies exclusion. tinyurl.com/ya5phexm

Happy #WorldLiverDay 2025! 🌍 Your liver performs over 500 vital functions—from detoxifying harmful substances to metabolising nutrients and regulating hormones. It deserves attention and care. This year's theme, #FoodIsMedicine, underscores the profound impact of our dietary

📢ESSENCE out now and it's a game changer for hepatology! GLP-1 RA improves histology AND metabolic health in MASH F2-3 fibrosis: 📍Absolute difference in fibrosis reduction of 15% = NNT 6.7 📍63% resolution of MASH vs 34% placebo. Wauw #LiverTwitter 🔗nejm.org/doi/full/10.10…

Dear friends and colleagues, It is with overwhelming sadness that we share news of the death of our colleague, mentor and friend, Rinaldo Bellomo. During recent days, both he and his family have received dedicated, expert and compassionate care from some of the finest in our ICU

A great week in Amsterdam for #EASL2025 and happy to present this work from our @AustinHealth team on importance of nutrition in #livertransplant

Real-world experience of home continuous terlipressin... : Official journal of the American College of Gastroenterology | ACG journals.lww.com/ajg/abstract/9…

Terlipressin impacts RAAS activation fg.bmj.com/content/early/…

Today, NEJM reports that Efruxifermin (an FGF21 agonist) is the first drug to reduce fibrosis in compensated cirrhosis due to NASH. This effect is seen after 96 weeks, so patience is key. Could combining Semaglutide make it even more powerful?

Is your liver transplant waiting list patient on apixaban? Read this 👇. Dr Katrina Tan, Avik Majumdar Marie Sinclair

To complement our recent study on #biologic safety in #IBD post–#liver #transplant, here’s our JAK inhibitor case series 👥 8 patients: 4 TOF, 1 UPA, 3 switched TOF→UPA ❌ No serious infections ⏳ 17-month median follow-up JCC 2024 📄 doi.org/10.1093/ecco-j…